Salute e Benessere

U.S. Institute of Peace Announces Four Finalists for 2023 Women Building Peace…

This year, USIP received over 150 nominations from 42 countries. This year, USIP received over 150 nominations from 42 countries. A council of distinguished experts and leaders has selected four finalists: Dr.Marie-Marcelle H. DeschampsofHaiti, Abir Haj Ibrahim ofSyria, Petronille Vaweka of theDemocratic Republic of the Congo, and Hamisa Zaja ofKenya. "The 2023 finalists are extraordinary women," said Lise Grande, USIP's president and CEO. "Leading on the front lines every...
PR Newswire
30/10/2023

King Faisal Specialist Hospital and Research Centre Highlights its Space…

At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space. These experiments encompass testing the immune cell response to inflammation in space, monitoring the activity of thousands of genes in immune cells exposed to inflammation over time, and tracking the changes in the lifespan of ribonucleic acid (mRNA) between space and Earth. Additionally, the pavilion simulates the inflammatory response to drug treatment...
Nasdaq GlobeNewswire
29/10/2023

King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone…

KFSH&RC's pioneering approach employed state-of-the-art robotic technology to conduct both donor and recipient surgeries with precision and minimal invasiveness, eliminating the need for a hybrid approach. While other centres offer minimally invasive liver transplants using mixed techniques, KFSH&RC is the only centre to complete a fully robotic living donor liver transplant surgery successfully.This accomplishment represents a significant leap forward in the history of...
Nasdaq GlobeNewswire
29/10/2023

88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the…

According to industry analysis, in 2022, the scale of China's medical equipment industry reached 957.34 billion yuan and it is projected this growth will continue. With the industry upgrading achieved through technological development of the medical industry, China's medical equipment industry is expected to maintain high growth, projecting to reach a market scale of 105.64 billion yuan in 2023. According to industry analysis, in 2022, the scale ofChina'smedical equipment industry reached957...
PR Newswire
29/10/2023

Alltech Joins Vital Group to Build an Industry Chain for High-End Medical…

The advanced components and materials such as cadmium zinc telluride (CZT) detectors and lutetium yttrium orthosilicate (LYSO) scintillation crystals developed by Vital Group open up more possibilities for Alltech's use of materials, technology, and equipment. With firm support from Vital Group, we are allowed to build up our portfolio of multi-modality imaging products. We are also speeding up the pace of our research and application of medical imaging technology, aiming to provide more…
PR Newswire
28/10/2023

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024

Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We have delivered a healthy performance in the first half of the financial year with 14% revenue growth accompanied by over 300 bps improvement in EBITDA margin. Our CDMO business returned to mid-teen growth with continued order inflows, especially for differentiated offerings and innovation related work. Our capacity expansion for Inhalation Anesthesia products is progressing well as we look to capitalize on the healthy demand in…
PR Newswire
28/10/2023

King Faisal Specialist Hospital and Research Centre Showcases its Health…

The hospital, through its pavilion participating in the exhibition accompanying the forum, will showcase its most prominent innovations and health solutions within the framework of its strategic directions aimed at strengthening its position as a pioneer of knowledge through education, research, innovation, and providing health care with the highest levels of quality and safety.His Excellency the CEO of King Faisal Specialist Hospital and Research Centre, Dr. Majid Ibrahim Al Fayyadh,...
Nasdaq GlobeNewswire
28/10/2023

Organon Returns Ebopiprant to XOMA

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – October 27, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today announced that XOMA will be receiving full worldwide rights on ebopiprant, an investigational, orally active, selective prostaglandin F2α (PGF2α) receptor antagonist, following the termination of the license agreement with Organon.After positive Phase 2a results in November...
Nasdaq GlobeNewswire
27/10/2023

DBV Technologies to Report Third Quarter 2023 Financial Results and Business…

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Tuesday, October 31 st, at 5:00 p.m. ET to review third quarter 2023 financial results and provide a business update.Interested participants may access this call via the below teleconferencing...
Nasdaq GlobeNewswire
27/10/2023

Groupe Casino: Details on payment obligations under financial instruments issued…

Details on payment obligations under financial instruments issued by the Group Paris, 27 October 2023Further to the press releases of 25 August 2023, 8 September 2023 and 4 October 2023, Casino Group states that, in respect of the EMTN bonds maturing in 2026 and the perpetual subordinated notes issued in 2005, the President of the Paris Commercial Court has granted grace periods ( délais de grâce ) until the end of the conciliation proceedings of Casino regarding the payment of claims due...
Nasdaq GlobeNewswire
27/10/2023

Junshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO…

thto 24 th. At the ESMO Congress 2023, Junshi Bioscience showcased a total of 11 clinical trials involving the groundbreaking immune-oncology drug, toripalimab (anti-PD-1 monoclonal antibody), in the forms of 1 late-breaking abstract, 2 proffered paper oral presentations, and 8 posters. These trials encompass ten diverse fields, including lung cancer, kidney cancer, head and neck cancer, breast cancer, colorectal cancer, cervical cancer, thymus cancer, and lymphoma. “This year's ESMO...
Nasdaq GlobeNewswire
27/10/2023

In Vitro Toxicology Testing Market Worth $17.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Browse in-depth TOC on "In Vitro Toxicology Testing Market" 392 - Tables 51 - Figures 415 - Pages In Vitro Toxicology Testing Market Scope: The consumables segment accounted for the largest share by product & service in the In vitro toxicology testing market in...
PR Newswire
27/10/2023

Medical Tourism Market to reach $273.7 Billion, Globally, by 2032 at 10.1% CAGR…

Request Sample of the Report on Medical Tourism Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/454 Request Sample of the Report on Medical Tourism Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/454 Medical tourism involves the act of traveling primarily to obtain medical treatment. Those participating in medical tourism may journey for a wide range of procedures, including innovative or experimental treatments, and they may opt to...
PR Newswire
27/10/2023

RAMSAY SANTE : Availability of the Universal Registration Document 2023

RELEASE Paris, le 27 October 2023 AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2023 Paris, 27 October 2023Ramsay Générale de Santé's 2023 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF (European Single Electronic Format) on Friday 27 October 2023, under number D.23-0778. It is available to the public under the conditions provided for by the regulations in force and can be consulted on the Ramsay Santé website: ...
Nasdaq GlobeNewswire
27/10/2023

StickIt Technology Shares Starts Trading on the CSE today October 27, 2023

StickIt is currently in the process of developing other line of products for nonsmokers' industry. The Company develops a unique cold drinking straw containing cannabinoids a functional experience with CBD, CBG, HHC for non-smoking users. In addition, the Company is developing a hot drink shaker stick containing cannabinoids with functional experience with CBD, CBG, HHC for non-smoking users. StickIt is currently in the process of developing other line of products for nonsmokers' industry...
PR Newswire
27/10/2023

"Two Expos and One Exhibition" Unveiled as Yulin Showcased to the Globe a High…

Themed "Big Economy for Small and Medium Enterprises, New Opportunities at the Yulin Expo", this year's Small and Medium Enterprises Expo was held in two separate venues: Yulin International Convention and Exhibition Center and Jiangnan Park. The theme of this year's China (Yulin) Traditional Chinese Medicine Expo is "Health, Development, Cooperation, Mutual Benefits", and the main venue was the Yulin Yinfeng International Traditional Chinese Medicine Port. Meanwhile, the…
PR Newswire
27/10/2023

Mass General Brigham Outlines Future of Health Care and Global Integrated Health…

Global Health Exhibition draws healthcare professionals and stakeholders from the Middle East and the Gulf, and Mass General Brigham's participation highlights its dedication to upholding a legacy of industry leadership, pioneering innovation, operational excellence, and unwavering commitment to global patient-centered collaboration. Global Health Exhibition draws healthcare professionals and stakeholders from theMiddle Eastand the Gulf, and Mass General Brigham's participation highlights...
PR Newswire
27/10/2023

Clario's Precision Motion Opal® technology powers University of Oxford…

Clario's scientific and technical expertise empowered the reliable collection of precise digital endpoints of movement enabling earlier detection of disease progression. This ultimately should accelerate the development of new medicines for PD, and potentially allow for earlier intervention for patients afflicted with this debilitating condition. Clario's scientific and technical expertise empowered the reliable collection of precise digital endpoints of movement enabling earlier detection of...
PR Newswire
27/10/2023

AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein…

PRESSRELEASEAC Immune Clinical Data Published inNature CommunicationsShow Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic ACI-12589 1delivers the first element of a precision medicine approach by enabling early and accurate diagnosis of a-syn pathology in certain diseasesClinical trial of ACI-12589 showed a specific and reproducible retention pattern in patients with MSA, a rare and difficult-to-diagnose neurodegenerative...
Nasdaq GlobeNewswire
27/10/2023

Unlocking Insights into the Global Acute Myeloid Leukemia (AML) Treatment…

Groundbreaking insights from the report include: Groundbreaking insights from the report include: Why Act Now? The timing of this AML market report is critical due to the emergence of novel therapies, evolving market dynamics, increased prevalence, awareness campaigns, economic and healthcare landscape changes, shifting patient outcomes, and the need for informed investment and strategic planning. By capturing current conditions and regulatory developments and aligning with global...
PR Newswire
27/10/2023

HighTide Therapeutics Inc. is Invited to Present at the 7th Edition of the…

Berberine ursodeoxycholate (HTD1801), a new molecular entity (NME) being developed by HighTide for the treatment of nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2DM), is an ionic salt formed between berberine and ursodeoxycholic acid. Berberine has been reported to combat aging and aging-related diseases via anti-oxidation and AMPK activation; and chronic ursodeoxycholic acid administration suppresses age-related inflammatory responses and improves age-related obesity and insulin…
PR Newswire
27/10/2023

PocDoc Selected by Roche Diagnostics to Join Startup Creasphere: A Step Towards…

An Innovation Collaboration with Roche Diagnostics through Startup Creasphere An Innovation Collaboration with Roche Diagnostics through Startup Creasphere This collaboration will explore innovative pilots, integrating PocDoc into Roche Diagnostics' broader POC ecosystem. With its history of being a global pioneer in healthcare solutions, Roche Diagnostics extends an exploration of innovation through its Creasphere programme, and PocDoc, with its unique and clinically relevant solutions,...
PR Newswire
27/10/2023

Global Medical Robotics Market is Forecast to Reach a Value of USD 28.77 Billion…

The Medical Robotics Market is witnessing rapid expansion within the healthcare industry, encompassing the development, manufacturing, and application of robotic technologies for medical purposes. These cutting-edge robots play an indispensable role in assisting surgeons, improving diagnostic capabilities, and enhancing patient care. Renowned for their precision, automation, and ability to provide minimally invasive solutions, they effectively reduce the risks associated with surgery and…
PR Newswire
27/10/2023

Navamedic ASA: Invitation to 2023 3rd quarter presentation

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: kathrine@navamedic.com Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail:kathrine@navamedic.com Lars Hjarrand, CFO, +47 917 62 842 E-mail:lars.hjarrand@navamedic.com About Navamedic Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform,...
PR Newswire
27/10/2023
Altri  Comunicati